Evidence map›Paper›PMID 24872317›Full record

ArticleAmerican journal of physiology. Renal physiology2014

RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.

Nagaraj Manickam, Mandakini Patel, Kathy K Griendling, Yves Gorin, Jeffrey L Barnes

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 121 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. MicroRNA 148a Suppresses Tuberculous Fibrosis by Targeting NOX4 and POLDIP2.International journal of molecular sciences · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Nagaraj ManickamThe Department of Medicine, Division of Nephrology, The University of Texas Health Science Center, San Antonio, Texas; and.
Mandakini PatelThe Department of Medicine, Division of Nephrology, The University of Texas Health Science Center, San Antonio, Texas; and.
Kathy K GriendlingThe Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Yves GorinThe Department of Medicine, Division of Nephrology, The University of Texas Health Science Center, San Antonio, Texas; and.
Jeffrey L BarnesThe Medical Research Service, Audie Murphy Memorial Veterans Administration Hospital, South Texas Veterans Health Care System, San Antonio, Texas; The Department of Medicine, Division of Nephrology, The University of Texas Health Science Center, San Antonio, Texas; and barnesj@uthscsa.edu.
The University of Texas Health Science Center · USEmory University · USMurphy Oil Corporation (United States) · USThe University of Texas Health Science Center at San Antonio · US

Funding

NOX4 and vascular smooth muscle differentiationR37HL038206 · NHLBI · EMORY UNIVERSITY · PI GRIENDLING, KATHY K · 2006 to 2015
$3.8M
Cellular Mechanisms of Renal Interstitial FibrosisR01DK080106 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BARNES, JEFFREY L · 2010 to 2014
$1.3M
NHLBI NIH HHS R37 HL038206NIDDK NIH HHS R01 DK080106NIDDK NIH HHS R01-DK-080106
6 · The paper itself

Abstract

The small G proteins Rac1 and RhoA regulate actin cytoskeleton, cell shape, adhesion, migration, and proliferation. Recent studies in our laboratory have shown that NADPH oxidase Nox4-derived ROS are involved in transforming growth factor (TGF)-β1-induced rat kidney myofibroblast differentiation assessed by the acquisition of an α-smooth muscle actin (α-SMA) phenotype and expression of an alternatively spliced fibronectin variant (Fn-EIIIA). Rac1 and RhoA are essential in signaling by some Nox homologs, but their role as effectors of Nox4 in kidney myofibroblast differentiation is not known. In the present study, we explored a link among Rac1 and RhoA and Nox4-dependent ROS generation in TGF-β1-induced kidney myofibroblast activation. TGF-β1 stimulated an increase in Nox4 protein expression, NADPH oxidase activity, and abundant α-SMA and Fn-EIIIA expression. RhoA but not Rac1 was involved in TGF-β1 induction of Nox4 signaling of kidney myofibroblast activation. TGF-β1 stimulated active RhoA-GTP and increased Rho kinase (ROCK). Inhibition of RhoA with small interfering RNA and ROCK using Y-27632 significantly reduced TGF-β1-induced stimulation of Nox4 protein, NADPH oxidase activity, and α-SMA and Fn-EIIIA expression. Treatment with diphenyleneiodonium, an inhibitor of NADPH oxidase, did not decrease RhoA activation but inhibited TGF-β1-induced α-SMA and Fn-EIIIA expression, indicating that RhoA is upstream of ROS generation. RhoA/ROCK also regulated polymerase (DNA-directed) δ-interacting protein 2 (Poldip2), a newly discovered Nox4 enhancer protein. Collectively, these data indicate that RhoA/ROCK is upstream of Poldip2-dependent Nox4 regulation and ROS production and induces redox signaling of kidney myofibroblast activation and may broader implications in the pathophysiology of renal fibrosis.

Indexed as

ActinsAnimalsCell Cycle ProteinsCell DifferentiationCell LineCell MovementEnzyme ActivationFibronectinsFibrosisKidneyMyofibroblastsNADPH Oxidase 4NADPH OxidasesOxidation-ReductionPhenotypeProtein Kinase InhibitorsActa2 protein, ratActinsCell Cycle ProteinsFibronectinsNADPH Oxidase 4NADPH OxidasesNox4 protein, ratPDIP38 protein, ratProtein Kinase Inhibitorsrac1 GTP-Binding ProteinRac1 protein, ratReactive Oxygen SpeciesrhoA GTP-Binding Proteinrho-Associated KinasesTransforming Growth Factor beta1fibrosisGTPasemyofibroblast differentiationNADPH oxidaseoxidative stresspolymerase (DNA-directed) δ-interacting protein 2Rho kinasetransforming growth factor-β1

Identifiers

PMID24872317
PMCPMC4101629
OpenAlexW2063821410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.